Entera Bio (ENTX) Share-based Compensation Growth (1y) (2022 - 2026)
Entera Bio (ENTX) Share-based Compensation Growth (1y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-69.95% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
0.18% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Entera Bio |
57.79 Mn |
53.65 Mn |
- |
11.26% |
| Date | Value |
|---|
| Mar 31, 2026 |
11.26% |
| Dec 31, 2025 |
25.44% |
| Sep 30, 2025 |
-0.11% |
| Jun 30, 2025 |
-14.88% |
| Mar 31, 2025 |
30.17% |
| Dec 31, 2024 |
77.99% |
| Sep 30, 2024 |
142.30% |
| Jun 30, 2024 |
26.69% |
| Mar 31, 2024 |
-10.08% |
| Dec 31, 2023 |
-33.33% |
| Sep 30, 2023 |
248.18% |
| Jun 30, 2023 |
-32.18% |
| Mar 31, 2023 |
-46.47% |
| Dec 31, 2022 |
29.62% |
| Sep 30, 2022 |
-82.48% |
| Jun 30, 2022 |
29.37% |
| Mar 31, 2022 |
194.80% |
